表紙：双極性障害の世界市場 (2022-2028年)：薬剤クラス (気分安定薬・抗けいれん薬)・タイプ (双極i型障害・双極II型障害) 別の規模・シェア・成長分析・予測

市場調査レポート

商品コード

1244243

双極性障害の世界市場 (2022-2028年)：薬剤クラス (気分安定薬・抗けいれん薬)・タイプ (双極i型障害・双極II型障害) 別の規模・シェア・成長分析・予測

Global Bipolar Disorder Market Size, Share, Growth Analysis, By Drug Class(Mood Stabilizers, Anticonvulsants), By Type(Bipolar I Disorder, Bipolar II Disorder) - Industry Forecast 2022-2028

出版日: 2022年10月13日 | 発行: SkyQuest

| ページ情報: 英文 157 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 830,828円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 971,912円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,112,996円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の双極性障害の市場規模は、2021年の53億米ドルから、予測期間中は2.12%超のCAGRで推移し、2028年には61億米ドルの規模に成長すると予測されています。

世界の双極性障害の有病率は近年増加傾向にあり、これが同市場の成長を牽引しています。WHOによると、双極性障害は世界の障害原因の第6位であり、世界で約6,000万人が罹患していると推定されています。双極性障害の有病率の増加は、ライフスタイルの変化、ストレスレベルの増加、遺伝などの要因に起因しています。

当レポートでは、世界の双極性障害の市場を調査し、市場概要、市場への各種影響因子の分析、技術・イノベーションの動向、市場規模の推移・予測、各種区分・地域別の内訳、競合情勢、主要企業のプロファイルなどをまとめています。

The global bipolar disorder market refers to the market for pharmaceuticals and treatment options used to manage bipolar disorder, which is a mental health condition characterized by episodes of depression and mania. The market for bipolar disorder treatment is driven by several factors, including the increasing prevalence of the disorder, growing awareness and diagnosis of the condition, and the introduction of new and innovative treatment options. The market includes a wide range of products such as mood stabilizers, antipsychotics, antidepressants, and psychotherapy.

Top-down and bottom-up approaches were used to estimate and validate the size of Global Bipolar Disorder Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

Global bipolar disorder market is segmented based on the drug class, type, and region. Based on the drug class, the global bipolar disorder market is segmented as mood stabilizers, anticonvulsants, antipsychotic drugs, antidepressant drugs, antianxiety drugs and others. Based on type, the global bipolar disorder market is segmented as, bipolar I disorder, bipolar II disorder, cyclothymic disorder, and others. Based on region, it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver

The global prevalence of bipolar disorder has been increasing in recent years, which is driving the growth of the bipolar disorder market. According to the World Health Organization, bipolar disorder is the sixth leading cause of disability worldwide, affecting an estimated 60 million people globally. The increasing prevalence of bipolar disorder is attributed to factors such as changing lifestyles, increasing stress levels, and genetic factors.

Restraint

Despite significant advances in the diagnosis and treatment of the bipolar disorder, the underlying causes of the condition are not yet fully understood. This can limit the development of effective treatments and make it more challenging to identify patients who are at risk of developing bipolar disorder.

Market Trends

Personalized medicine is an emerging trend in the bipolar disorder market, with a growing focus on developing targeted therapies that address the specific needs of individual patients. Advances in genetics and biomarker research are helping to identify subtypes of bipolar disorder, which could lead to more effective and personalized treatments. Additionally, the development of digital health tools, such as mobile apps and wearables, is enabling the collection of real-time patient data that can be used to inform personalized treatment plans. As the demand for personalized medicine continues to grow, we can expect to see more investment in research and development of targeted therapies for bipolar disorder.

Executive Summary

Market overview

Exhibit: Executive Summary - Chart on Market Overview
Exhibit: Executive Summary - Data Table on Market Overview
Exhibit: Executive Summary - Chart on Global Global Bipolar Disorder Market Characteristics
Exhibit: Executive Summary - Chart on Market by Geography
Exhibit: Executive Summary - Chart on Market Segmentation
Exhibit: Executive Summary - Chart on Incremental Growth
Exhibit: Executive Summary - Data Table on Incremental Growth
Exhibit: Executive Summary - Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
Drivers
Opportunities
Restraints
Challenges
SWOT Analysis

KEY MARKET INSIGHTS

Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
Macroeconomic Indicators

COVID IMPACT

Introduction
Impact On Economy-scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
Revised Market Size
- Exhibit: Data Table on Global Global Bipolar Disorder Market size and forecast 2021-2027 ($ million)
Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
Drivers
Opportunities
Restraints
Challenges
Regulatory Landscape
- Exhibit: Data Table on regulation from different region
SWOT Analysis
Porters Analysis
- Competitive rivalry
Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Global Bipolar Disorder Market by Drug Class
Market segments
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Data table on Market share 2021-2027 (%)
Mood Stabilizers
- Market Estimates & Forecast, 2020-2027
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
Anticonvulsants
- Market Estimates & Forecast, 2020-2027
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
Antipsychotic Drugs
- Market Estimates & Forecast, 2020-2027
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
Antidepressant Drugs
- Market Estimates & Forecast, 2020-2027
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
Antianxiety Drugs
- Market Estimates & Forecast, 2020-2027
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
Other
- Market Estimates & Forecast, 2020-2027
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)

Global Global Bipolar Disorder Market by Type

Market segments
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Data table on Market share 2021-2027 (%)
Bipolar I Disorder
- Market Estimates & Forecast, 2020-2027
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
Bipolar II Disorder
- Market Estimates & Forecast, 2020-2027
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
Cyclothymic Disorder
- Market Estimates & Forecast, 2020-2027
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
Others
- Market Estimates & Forecast, 2020-2027
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)

Market Size by Region

Chart on Market share by geography 2021-2027 (%)
Data Table on Market share by geography 2021-2027(%)
North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
- France
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
- India
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

Competitive Landscape
- Total number of companies covered
Exhibit: companies covered in the report, 2021
- Top companies market positioning
Exhibit: company positioning matrix, 2021
- Top companies market Share
Exhibit: Pie chart analysis on company market share, 2021(%)
Allergan (Ireland)AstraZeneca (UK)Eli Lilly and Company (US)GlaxoSmithKline (UK)Abbott (US)Bristol-Myers Squibb (US)Johnson & Johnson (US)Pfizer Inc. (US)Cephalon Inc. (US)Otsuka America Pharmaceutical Inc. (US)Gedeon Richter plc (Hungary)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
Allergan (Ireland)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
AstraZeneca (UK)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
Eli Lilly and Company (US)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
GlaxoSmithKline (UK)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
Abbott (US)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
Bristol-Myers Squibb (US)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
Johnson & Johnson (US)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
Pfizer Inc. (US)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
Cephalon Inc. (US)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
Otsuka America Pharmaceutical Inc. (US)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
Gedeon Richter plc (Hungary)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments

双極性障害の世界市場 (2022-2028年)：薬剤クラス (気分安定薬・抗けいれん薬)・タイプ (双極i型障害・双極II型障害) 別の規模・シェア・成長分析・予測

Global Bipolar Disorder Market Size, Share, Growth Analysis, By Drug Class(Mood Stabilizers, Anticonvulsants), By Type(Bipolar I Disorder, Bipolar II Disorder) - Industry Forecast 2022-2028

目次

エグゼクティブサマリー

市場概要

親市場の分析

市場概要

市場規模

主要な市場の洞察

COVID-19の影響

市場力学と見通し

世界の双極性障害市場：タイプ別

市場規模：地域別

主な企業プロファイル

Table of Contents

Executive Summary

Market overview

Parent Market Analysis

Market overview

Market size

KEY MARKET INSIGHTS

COVID IMPACT

MARKET DYNAMICS & OUTLOOK

Global Global Bipolar Disorder Market by Type

Market Size by Region

KEY COMPANY PROFILES